DNMT1 and neoplasm: DNMT inhibition stimulates the recruitment of MDSCs to TME, dampening antitumor immunity.655 Besides the tumor-intrinsic mechanisms, low chemical stability and poor pharmacokinetic properties of the nucleoside DNMT inhibitors also account for the limited clinical efficacy.